Increased α2-6 sialyltransferase activity in IBD leads to abnormal synthesis of sialyl-Tn (Neu5Acα2-6GalNAc-) and prevents the normal extension of the colonic mucin O-glycan chains. Here, MUC5AC is linked to inflammatory bowel disease.